Norepinephrine (NE) and epinephrine (Epi) help maintain normal blood glucose levels by stimulating glucagon release, glycogenolysis, and food consumption, and by inhibiting insulin release. The absence of NE and Epi in dopamine ␤-hydroxylase-null (Dbh Ϫ/Ϫ ) mice results in chronically low blood glucose levels, an impaired glucagon response to hypoglycemia, and elevated insulin levels. Nevertheless, Dbh Ϫ/Ϫ mice have normal glycogen levels and degrade it normally during a fast. Dbh Ϫ/Ϫ mice defend blood glucose levels better than controls in an insulin tolerance test but have increased sensitivity to glucose-stimulated insulin secretion and respond normally in a glucose tolerance test. Pharmacological evidence indicates that the hyperinsulinemia results from lack of ␣2-adrenoreceptor stimulation and increased parasympathetic tone. Dbh Ϫ/Ϫ mice eat normally after challenges with modest levels of insulin or 2-deoxyglucose but fail to eat under more extreme conditions when control mice still do. We suggest that the primary difference in Dbh Ϫ/Ϫ mice is chronic hyperinsulinemia associated with an altered glucose set point. However, these animals compensate for NE/Epimediated glycogenolysis and feeding. (Endocrinology 144: [4427][4428][4429][4430][4431][4432] 2003) I N A NORMAL ANIMAL, blood glucose concentrations are maintained in a relatively narrow range. This regulation is complex and depends on the integration of behavioral and physiological processes. The sympathetic nervous system (SNS) has a significant role in mediating many of these processes, including the regulation of hormone secretion from the pancreas as well as effects on glycogenolysis in the liver and lipolysis in adipose tissue during hypoglycemia. Defining the roles of norepinephrine (NE) and epinephrine (Epi) in these processes has been difficult because of the redundant control mechanisms that serve to maintain glucose homeostasis. Whereas insulin secretion from the pancreatic ␤-cell is primarily mediated by circulating glucose levels, insulin secretion is also controlled by opposing actions of the parasympathetic nervous system and SNS (1, 2). Within the pancreas, release of NE by sympathetic neurons inhibits insulin secretion, whereas release of acetylcholine by parasympathetic neurons has the opposite effect (3). There is also evidence that these neurotransmitters modulate each other's release in the pancreas (4). Understanding this regulation is further complicated because NE and acetylcholine act on multiple receptor types that modulate different signal transduction pathways important for pancreatic secretion. For example, although the predominate effect of NE release in the pancreas is to inhibit insulin secretion through ␣2-adrenoreceptor (␣2AR) activation, ␤ AR activation stimulates insulin secretion (5). Additionally, other factors participate in the regulation of insulin release from the ␤-cells including neuropeptides released by the autonomic fibers, and incretins released from the gut (6).
I N A NORMAL ANIMAL, blood glucose concentrations are maintained in a relatively narrow range. This regulation is complex and depends on the integration of behavioral and physiological processes. The sympathetic nervous system (SNS) has a significant role in mediating many of these processes, including the regulation of hormone secretion from the pancreas as well as effects on glycogenolysis in the liver and lipolysis in adipose tissue during hypoglycemia. Defining the roles of norepinephrine (NE) and epinephrine (Epi) in these processes has been difficult because of the redundant control mechanisms that serve to maintain glucose homeostasis. Whereas insulin secretion from the pancreatic ␤-cell is primarily mediated by circulating glucose levels, insulin secretion is also controlled by opposing actions of the parasympathetic nervous system and SNS (1, 2) . Within the pancreas, release of NE by sympathetic neurons inhibits insulin secretion, whereas release of acetylcholine by parasympathetic neurons has the opposite effect (3) . There is also evidence that these neurotransmitters modulate each other's release in the pancreas (4) . Understanding this regulation is further complicated because NE and acetylcholine act on multiple receptor types that modulate different signal transduction pathways important for pancreatic secretion. For example, although the predominate effect of NE release in the pancreas is to inhibit insulin secretion through ␣2-adrenoreceptor (␣2AR) activation, ␤ AR activation stimulates insulin secretion (5) . Additionally, other factors participate in the regulation of insulin release from the ␤-cells including neuropeptides released by the autonomic fibers, and incretins released from the gut (6) .
The redundancy in the regulation of blood glucose is further demonstrated in the responses to hypoglycemia. When blood glucose levels fall due to starvation or the administration of insulin, behavioral and physiological responses are activated to restore euglycemia. Behaviorally, dopamine ␤-hydroxylase (DBH)-containing neurons in the hindbrain that innervate the hypothalamus are implicated in the feeding response to glucose deprivation (7) . The physiological responses to low blood glucose include direct effects on hormone release by ␣-and ␤-cells as well as activation of SNS to release NE, and activation of adrenals to release Epi and corticosterone. NE/Epi stimulate glucagon release and inhibit insulin release from the pancreas (8) . Glucagon, together with NE, Epi, and corticosterone, stimulate glycogenolysis and gluconeogenesis in the liver (3, 9) . In addition, NE and Epi stimulate the release of free fatty acids from adipose tissue, which decrease glucose utilization in the periphery preserving it for the brain (10) . Studies in which each of these mediators was blocked, either alone or in combination, during an insulin-induced hypoglycemic challenge in humans indicated that actions of glucagon were the most critical for restoration of euglycemia (11) . Only in the absence of glucagon did the loss of sympathetic input affect recovery. Mice lacking a functional DBH gene (Dbh Ϫ/Ϫ ) are unable to produce NE and Epi (12, 13) . These mice die in utero, unless they are rescued with dihydroxyphenylserine, which can be converted to NE by l-aromatic amino acid decarboxylase. After parturition, Dbh Ϫ/Ϫ mice survive without further intervention, but they are approximately 20% smaller than control littermates and cold intolerant (13) . They have an increased metabolic rate, are slightly hyperphagic compared with control mice, and have normal adiposity. Experiments with Dbh Ϫ/Ϫ mice in which the SNS remains anatomically intact, except for the loss of NE and Epi, have allowed us to evaluate the consequences of chronic depletion of these catecholamines on the regulation of blood glucose levels.
Abbreviations: AR, Adrenoreceptor; DBH, dopamine ␤-hydroxylase; 2DG, 2-deoxyglucose; Epi, epinephrine; NE, norepinephrine; SNS, sympathetic nervous system.
Materials and Methods

Animal care
Dbh Ϫ/Ϫ mice were created and maintained on a mixed C57BL/6J and 129SvCPJ hybrid background (12) . Dbh ϩ/Ϫ littermates, which express normal amounts of NE and Epi (14) , were the control mice in all experiments. No differences were detected between males and females in any of the experiments conducted. Mice were maintained on a 12-h light, 12-h dark cycle and had ad libitum access to water and standard rodent chow (PicoLab, St. Louis, MO; Rodent Diet 5053), unless otherwise indicated. All procedures were conducted in accordance with guidelines established by the National Institutes of Health and the University of Washington Animal Care Committee.
Fasting blood glucose levels
Food was removed from 12-to 16-wk-old female mice at lights on (0700 h), and the first blood sample was collected from the tail vein of conscious mice. Subsequent samples were collected at the indicated times. All samples were collected, placed on ice, centrifuged, and blood glucose levels were measured using Trinder reagent (Sigma, St. Louis, MO).
Fasting plasma insulin measurements
Eight-week-old male and female mice were fasted for 4 or 12 h before blood was collected from the saphenous vein. The samples were centrifuged, plasma removed, and insulin measured using an ultrasensitive mouse insulin ELISA (Alpco Diagnostics, Windham, NH).
Insulin tolerance test
Eight-to 16-wk-old female mice were fasted for 4 h before the start of the test. Various doses of human insulin (Humulin, Lilly, Indianapolis, IN) in saline vehicle were administered ip and tail blood was collected for blood glucose measurements using a blood-glucose analyzer (Hemocue, Lake Forest, CA). Blood glucose level is expressed as normalized blood glucose level where blood glucose values were normalized to the time 0 value (i.e. time 0 value ϭ 1 for each animal).
Pancreatic insulin extraction
Pancreata of 20-wk-old mice were dissected and homogenized in acid ethanol (15) . Insulin was quantified using the ultrasensitive mouse insulin ELISA.
Glucose tolerance test
Sixteen-week-old female mice were fasted 12 h before the start of the test. Glucose in saline vehicle was administered ip at a dose of 2 g/kg, and blood was collected at various times for blood glucose measurements using a Hemocue blood glucose analyzer. Blood glucose level is expressed as normalized blood glucose level where blood glucose values were normalized to the time 0 value (i.e. time 0 value ϭ 1 for each animal).
Stimulated insulin secretion
Eight-to 16-wk-old male and female mice were fasted for 4 h before administration ip of glucose (2 g/kg) or arginine (1 g/kg) in saline vehicle. Blood samples were collected from the saphenous vein at the indicated time points, and plasma insulin was measured using the ultrasensitive mouse insulin ELISA.
Basal insulin secretion
Eight-to 16-wk-old and female mice were fasted for 4 h before administration ip of clonidine at 50 nmol/kg or atropine methyl bromide at 5.2 mmol/kg in saline vehicle. Blood samples were collected from the saphenous vein 30 min after the injection and plasma insulin was measured using the ultrasensitive mouse insulin ELISA.
Glucagon measurements
Sixteen-week-old male and female mice were fasted 4 h before administration ip of at 2-deoxyglucose (2DG) at 250 mg/kg or saline vehicle and blood was collected 30 min later by a retro-orbital bleed. Sixteen-week-old female mice were fasted 4 h before administration ip of insulin at 1.5 U/kg or saline vehicle and blood was collected 1 h later by a retro-orbital bleed. The blood samples were immediately centrifuged, and plasma was frozen until glucagon measurements were made by RIA (Linco, St. Charles, MO).
Corticosterone measurements
For the basal corticosterone measurements, blood was collected from mice within 2 min of the researcher touching the cage. Insulin-induced corticosterone measurements were made from blood collected from mice fasted 4 h before insulin administration. Insulin was administered ip at a dose of 1 U/kg, and blood was collected 30 min later from the saphenous vein. Corticosterone levels were measured using the OTECIA rat and mouse corticosterone kit (Alpco Diagnostics, Windham, NH).
Glycogen measurements
Livers of 20-to 30-wk-old mice that were fasted for the indicated number of hours were dissected and homogenized in perchloric acid buffer and assayed using amylogluocosidase as described (16) . Glucose levels were quantified using Trinder reagent.
Feeding experiments
Ad libitum-fed 8-wk-old male mice were administered saline vehicle or insulin ip, at approximately 1200 h, at the indicated doses and food consumption was measured 4 h later. Mice were given greater than 1-wk recovery time between insulin injections. Ad libitum-fed male mice were administered saline vehicle or 2DG at 250 mg/kg ip, and food consumption was measured 4 h later.
Statistical analysis
All data are expressed as mean Ϯ sem. Data were analyzed using Student's t test or Wilcoxon-Mann-Whitney U test when comparing two groups, and ANOVA followed by a Tukey or Dunn multiple comparisons post hoc tests if significant differences among groups were found, when comparing more than two groups. 
Results
Dbh Ϫ/Ϫ mice have low blood glucose levels and are hyperinsulinemic
Blood glucose concentrations were measured in female Dbh Ϫ/Ϫ and control mice at the start of the light cycle and at various time points during a 24-h fast. At all time points, the blood glucose concentrations of the Dbh Ϫ/Ϫ mice were approximately 25% lower than controls (Fig. 1A) . Male Dbh Ϫ/Ϫ mice were also found to maintain blood glucose concentrations approximately 25% lower than controls.
Because NE and Epi can inhibit insulin release from pancreatic ␤-cells (17), we measured plasma insulin concentrations in Dbh Ϫ/Ϫ mice after either a 12-or 4-h fast because there were no differences between males and females the values were combined. After the 12-h fast, Dbh Ϫ/Ϫ mice had approximately 6-fold higher plasma insulin concentrations than control mice (Fig. 1B) , whereas after the 4-h fast the levels were elevated approximately 4-fold (Fig. 1C) . The number and size of pancreatic islets appeared normal in Dbh Ϫ/Ϫ mice, and no differences were apparent after insulin immunohistochemistry (data not shown). Quantitification of total pancreatic insulin by ELISA confirmed this result (Dbh Ϫ/Ϫ mice: 138 Ϯ 13.6, controls 167 Ϯ 23.9 ng insulin/mg pancreas, P Ͼ 0.05).
Increased plasma insulin levels can result in insulin resistance (18) . An insulin tolerance test can be used as an indicator of insulin resistance. In an insulin tolerance test, the blood glucose levels of Dbh Ϫ/Ϫ mice fell less than control mice at a 1.0-U/kg dose of insulin ( Fig. 2A) . A dose-response experiment indicated that the Dbh Ϫ/Ϫ mice had a smaller percentage decrease in blood glucose at doses of insulin between 0.75 and 1.5 U/kg (Fig. 2B) . Whereas the normalized blood glucose levels of the Dbh Ϫ/Ϫ mice fell less than that of control mice, the actual blood glucose levels for both groups of mice fell to approximately 2.2 mmol/liter at the 0.75-U/kg, 1.0-U/kg, and 1.5-U/kg doses of insulin (Fig. 2C) .
Dbh
Ϫ/Ϫ mice respond normally to a glucose tolerance test
Although Dbh Ϫ/Ϫ mice appeared insulin resistant, they had a normal response in the glucose tolerance test (Fig. 3A) . One way that Dbh Ϫ/Ϫ mice could maintain normal glucose tolerance, while being insulin resistant, would be to secrete more insulin in response to a glucose challenge. Indeed, Dbh Ϫ/Ϫ mice had increased plasma insulin concentrations over baseline at the 2-min time point measured, whereas control mice had a measurable increase of insulin only at 30 min (Fig. 3B) . The insulin response of Dbh Ϫ/Ϫ mice was not, however, hypersensitive to arginine, another insulin secretagogue. Arginine administration resulted in a smaller increase in plasma insulin concentrations over baseline in the Dbh Ϫ/Ϫ mice than controls, but the effect lasted longer (Fig. 3C) .
Activation of ␣2AR or blockade of muscarinic receptors normalizes plasma insulin levels in Dbh
To test if the hyperinsulinemia in the Dbh Ϫ/Ϫ mice was due to lack of signaling through the inhibitory ␣2AR, we administered clonidine, an ␣2AR agonist. Clonidine treatment caused plasma insulin of Dbh Ϫ/Ϫ mice to fall to normal levels; it also lowered insulin levels in control mice (Fig. 4) , as has been previously reported (19) . The inhibitory tone of the sympathetic input to ␤-cells is normally countered by cholinergic input from the parasympathetic nerves. Administration of atropine methyl bromide, a cholinergic antagonist that does not cross the blood-brain barrier, normalized plasma insulin levels in Dbh Ϫ/Ϫ mice without affecting controls (Fig. 4) . Atropine methyl bromide administration did not affect blood glucose concentrations in either Dbh Ϫ/Ϫ or control mice for up to 90 min after injection (data not shown). Thus, islets of Dbh Ϫ/Ϫ mice not only lack sympathetic tone, but also may have greater parasympathetic tone. Parasympathetic tone may be elevated due to lack of ␣2AR inhibition of parasympathetic terminals in the pancreas, or to changes in central control of parasympathetic output to the pancreas (1).
FIG. 1. Dbh
Ϫ/Ϫ mice are hypoglycemic and hyperinsulinemic. A, Blood glucose levels during a 24-h fast in Dbh Ϫ/Ϫ (dotted line) and control mice (solid line) (n ϭ 14 Dbh Ϫ/Ϫ and 15 control mice); ***, P Ͻ 0.001. B, Plasma insulin levels after a 12-h fast in Dbh Ϫ/Ϫ (n ϭ 11) and control mice (n ϭ 10); **, P Ͻ 0.01. C, Plasma insulin levels after a 4-h fast in Dbh Ϫ/Ϫ (n ϭ 14) and control mice (n ϭ 16); **, P Ͻ 0.01. 
FIG. 2. Dbh
Glycogenolysis by Dbh Ϫ/Ϫ mice is normal, despite an abnormal glucagon response
A normal counterregulatory response to transient hypoglycemia includes stimulation of glycogenolysis and gluconeogenesis. NE/Epi stimulate these processes both by enhancing glucagon release from the pancreatic ␣-cells, which then activates hepatic glucagon receptors, and by directly activating ␤〈Rs on hepatic cells (8) . Basal glucagon levels were normal in Dbh Ϫ/Ϫ mice (Fig. 5A ). Immunocytochemistry with an antibody to glucagon revealed that the number and peri-islet distribution of pancreatic ␣-cells was normal (data not shown). However, glucagon release in response to insulin-induced hypoglycemia was severely blunted (Fig.  5A) , even though the blood glucose levels were the same (Fig.  5B) . Likewise, the release of glucagon by Dbh Ϫ/Ϫ mice, in response to administration of 2DG, a nonmetabolizable glucose analog that acts centrally (7), was also impaired compared with controls (Fig. 5C) .
The glucocortiocoid levels of Dbh Ϫ/Ϫ and control mice were the same after insulin administration. Although basal levels of corticosterone were elevated in the Dbh Dbh Ϫ/Ϫ mice have normal levels of hepatic glycogen despite chronically low blood glucose levels (Fig. 5D) . Surprisingly, glycogenolysis by Dbh Ϫ/Ϫ mice proceeds normally during a fast even though they lack NE/Epi and have impaired ability to stimulate glucagon release (Fig. 5D) .
Dbh
Ϫ/Ϫ mice have a normal food intake response to moderate doses of insulin or 2DG DBH-containing neurons in the brain have been implicated in the feeding responses to glucose deprivation (7, 21), so we measured food intake after administration of insulin or 2DG. In response to administration of insulin at 1, 1.5, 2, 2.5, or 3.5 U/kg, the Dbh Ϫ/Ϫ and the control mice increased food intake an average of approximately 2.7-fold over their food intake after vehicle; the response to 1.5 U/kg is shown (Fig. 6A) . At this dose of insulin, blood glucose concentrations of the Dbh Ϫ/Ϫ and control mice were comparable throughout a 2-h insulin tolerance test (data not shown). However after administering insulin at 5 U/kg, Dbh Ϫ/Ϫ mice failed to respond by eating more, whereas control mice were still able to respond, eating approximately 3.5-fold more than after vehicle (Fig. 6A) . After a 5-U/kg dose of insulin, blood glucose concentrations of Dbh Ϫ/Ϫ mice fell to approximately 2.5 mmol/liter within 30 min, a level at which cognitive dysfunction occurs (22) , whereas blood glucose levels of control mice did not reach approximately 2.5 mmol/liter until approximately 90 min (Fig. 6B ). Blood glucose levels for both groups of animals fell to approximately 1.4 mmol/liter by the 2-h time point, at which point the experiment was ended. Similarly, Dbh Ϫ/Ϫ mice increased food intake normally in response to administration of 2DG at 250 mg/kg (Fig. 6C ), but at 500 mg/kg the Dbh Ϫ/Ϫ mice became obtunded, whereas controls were still able to respond (data not shown).
Discussion
A main finding of this analysis is that blood glucose concentrations of Dbh Ϫ/Ϫ mice are consistently approximately 25% lower than control mice. Because Dbh Ϫ/Ϫ mice are NE/ Epi deficient from birth, developmental adjustments in neural circuitry or regulation may contribute to this phenotype. Presumably, blood glucose level is set and regulated by the hypothalamus and other brain regions like the hindbrain, which contain glucose-sensing neurons. Therefore, the low blood glucose in Dbh Ϫ/Ϫ mice suggests that NE and Epi, may be necessary centrally for defining the level at which blood glucose is maintained. The data indicate that chronic hyperinsulinemia may also contribute to this phenotype. The total pancreatic insulin content, as well as the number and appearance of the islets, was normal. Therefore, it appears that the hyperinsulinemia is caused by changes in the regulation of insulin secretion. Indeed, the Dbh Ϫ/Ϫ mice show enhanced insulin secretion in response to glucose challenge, but the initial response of the ␤-cells to arginine was normal.
To explain the changes in insulin secretion, we propose a model in which chronic activation of pancreatic ␣2AR by NE released from sympathetic neurons, and Epi from the adrenals, normally provides tonic inhibition of insulin secretion that is counteracted when glucose levels rise (23) . In the absence of NE, this tonic inhibition is not present, resulting in chronically elevated insulin secretion. The ␣2AR response appears to be intact in the Dbh Ϫ/Ϫ mice because administration of clonidine lowers circulating insulin to normal levels. This clonidine effect could be due to both stimulation of ␣2AR on ␤-cells and those located on parasympathetic terminals in the pancreas, because methyl atropine also normalized insulin levels in the Dbh Ϫ/Ϫ mice. The fact that atropine could decrease insulin secretion only in the Dbh Ϫ/Ϫ mice suggests that NE/Epi may inhibit the parasympathetic input to the ␤-cell. Thus, we propose that when NE and Epi are absent, the lack of inhibitory sympathetic tone coupled with enhanced stimulatory parasympathetic input to the pancreas results in increased basal insulin secretion. Dbh Ϫ/Ϫ mice appear to be insulin resistant in an insulin tolerance test; however, to clearly establish insulin resistance, hyperinsulinemic-euglycemic clamp studies need to be performed. The normalized blood glucose levels of the Dbh Ϫ/Ϫ mice fall less than controls when challenged with insulin, although blood glucose levels fall to about the same absolute level in both groups. Because increased insulin and glucocorticoids have each been associated with insulin resistance (18, 24) and the Dbh Ϫ/Ϫ mice have elevated levels of both hormones under basal conditions, the apparent insulin resistance may be due to a combination of these effects. In addition, it has been shown that central effects of glucocorticoids stimulate vagal output to the pancreas (25) , which would contribute to enhanced parasympathetic tone in Dbh Ϫ/Ϫ mice. Low blood glucose normally activates the SNS, which stimulates glucagon release leading to glycogenolysis and gluconeogenesis to restore euglycemia. Thus, we predicted that in the absence of NE in the SNS, basal glucagon levels would be lower and glycogen levels would be higher than normal. However, both were normal indicating that Dbh Ϫ/Ϫ mice had achieved homeostasis at a new blood glucose set point. The elevated levels of insulin may help maintain normal glycogen levels. As predicted, the release of glucagon was impaired in response to administration of insulin or 2DG. Despite impaired release of glucagon, and the lack of NE/Epi, glycogen is degraded normally during a fast, raising the question of what signals glycogenolysis in the absence of these classical signals.
Activation of DBH-containing neurons in the brain stem has been implicated in both feeding and autonomic responses to glucose deprivation (7, 21) . However, Dbh Ϫ/Ϫ mice have normal feeding responses to doses of insulin that lower blood glucose much more than after a 24-h fast (compare Fig. 1A with Fig. 5B ). Dbh Ϫ/Ϫ mice also eat more than normal in response to modest doses of 2DG, a glucose analog that interferes with glycolysis and stimulates glucose-sensitive neurons in the brain stem and hypothalamus, which in turn activate both sympathetic output and neural circuits that control feeding activity (7, 21) . Because ablation of DBHcontaining neurons that project to the hypothalamus prevents the feeding response to glucopenia (7), neurotransmitters made by those neurons, other than NE/Epi, probably mediate the feeding response. When very high levels of insulin are administered, blood glucose falls precipitously to levels that compromise a normal behavioral response. Because the Dbh Ϫ/Ϫ mice are always hypoglycemic, they reach that critical level before the controls. Dbh Ϫ/Ϫ mice respond to a 48-h fast with similar weight loss as controls (ϳ15%), and they recover after refeeding (data not shown), indicating that they do not reach critical glucose levels under these conditions; however, the mechanisms involved in defending body functions during prolonged starvation remain to be explored.
